Treatment News

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News


May 27, 2015
Solid Evidence Backing Early HIV Treatment Finally Arrives
For the first time, a major clinical trial has found that starting antiretroviral treatment soon after HIV diagnosis reduces the risk of sickness and death when compared with delaying treatment until HIV disease progresses.
May 26, 2015
Certain HIV Meds Raise Risk of Heart Trouble
Various HIV antiretrovirals are linked to a raised risk of cardiovascular problems, although the overall risk of such an outcome is still low.
May 21, 2015
Vaginal Bacteria May Raise HIV Risk in South Africa
Differences in the bacterial colonies in the genital tracts of South African women, when compared with American women, may raise the South Africans’ relative risk of HIV infection.
HIV Infection in Young Gay Men Linked to Lower Socioeconomic Status
Young men who have sex with men in a New York City area cohort are more likely to contract HIV if they are of low socioeconomic status.
May 20, 2015
PrEP Reaches Top Effectiveness After a Week of Daily Dosing
Daily Truvada as pre-exposure prophylaxis (PrEP) against HIV takes five to seven days to reach top estimated effectiveness among gay men.
May 19, 2015
Pot Lowers HIV/HCV-Coinfected People’s Insulin Resistance Risk
Marijuana use among people coinfected with HIV and hepatitis C is linked with a lowered risk of insulin resistance.
May 18, 2015
Newer Non-Nuke HIV Meds May Allow for Lower Adherence
Newer NNRTI–based antiretroviral regimens may keep HIV viral loads suppressed when adherence levels are as low as 85 percent.
May 14, 2015
Central Appalachian Jump in Hep C Linked to Opioid Use
A rise in opioid dependency and in the rate of injection drug use in four central Appalachian states has occurred in tandem with a rising hepatitis C incidence.
PrEP Prescriptions on Dramatic Upswing in New York State
In less than a year, the number of New York State residents receiving Truvada as PrEP prescriptions through Medicaid has nearly tripled.
May 13, 2015
HIV-Positive Women Often Don’t Discuss Contraception With MDs
Reproductive-age women living with HIV and their physicians inconsistently and inadequately discuss contraception.
May 12, 2015
GSK Gives $40 Million to UNC Chapel Hill to Seek Cure for HIV
GlaxoSmithKline (GSK) has joined with University of North Carolina at Chapel Hill to pursue HIV cure strategies.
May 11, 2015
Backlash to New York City’s Fear-Based HIV Prevention Campaign
The New York City health department's recent fear-based HIV prevention campaign may have led to unintended consequences by stigmatizing young black and Latino men who have sex with men. 
May 08, 2015
PrEP-Delivering Subdermal Implant Shows Promise in Animal Study
A subdermal implant that delivers tenofovir alafenamide (TAF) has shown promise as an alternative to daily PrEP in an animal study.
May 07, 2015
People With HIV Have Strong Interest in Joining Cure Research
HIV-positive people have a high level of interest in participating in HIV cure research, the risks notwithstanding.
May 06, 2015
People Tend to Seek HIV Prevention and Testing Info at Week’s Outset
Individuals are more likely to seek out HIV prevention and testing information at the beginning of the week, and are more inclined to engage in risky sexual behaviors over the weekend.
May 05, 2015
Joint Pain Flares Among People With HIV, Hepatitis C or Both
People with HIV and hepatitis C virus, as well as those who are coinfected with both viruses, report high levels of joint pain.
A New, More Reliable Way to Gauge HIV-Related Cognitive Dysfunction
A new statistical means of assessing HIV-associated neurocognitive dysfunction (HAND) is more reliable than the so-called Frascati and Gisslén methods.
May 04, 2015
Individual HIV Meds Are Just as Effective as Combo Pills
Multi-antiretroviral combination tablets appear to combat HIV no better than regimens that include individual tablets.
May 01, 2015
HIV Vaccine Boosts Effects of Antiretrovirals
A vaccine containing a protein instrumental to HIV replication improves the overall effectiveness of antiretrovirals.
More Treatment News

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.

Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ



Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Poll
Do you think condoms should be mandated in adult films?
Yes
No

Survey
Plan of Action

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2015 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.